EVAX NASDAQ
Evaxion Biotech A/S
1W: -4.2%
1M: +4.2%
3M: -5.3%
YTD: -32.1%
1Y: -27.9%
3Y: -92.4%
5Y: -99.3%
$3.20
+0.02 (+0.63%)
Weekly Expected Move ±5.9%
$3
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7M
+48.6% ▲
Capital Expenditures
$11K
+0.0% ▲
5Y CAGR: -51.1%
Free Cash Flow
-$7M
+48.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$17M
+4583.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$25M | -$23M | -$22M | -$11M | -$8M |
| Depreciation & Amort. | $344K | $571K | $615K | $607K | $617K |
| Stock-Based Comp. | $1M | $942K | $479K | $357K | $0 |
| Change in Working Capital | $1M | -$3M | $2M | $520K | -$137K |
| Other Non-Cash Items | -$171K | -$243K | $3M | -$3M | $606K |
| Operating Cash Flow | -$22M | -$26M | -$18M | -$13M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$292K | -$87K | $0 | -$11K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$6K | -$3K | -$3K |
| Investment Sales | $30K | $24K | $0 | $0 | $0 |
| Other Investing | -$60K | -$13 | $133 | $0 | $0 |
| Investing Cash Flow | -$1M | -$268K | -$93K | -$3K | -$14K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$289K | $7M | -$632K | -$1M | -$400K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$4M | $0 | $2M | -$2M | -$353K |
| Financing Cash Flow | $50M | $8M | $11M | $13M | $22M |
| Net Change in Cash | $26M | -$19M | -$8M | $369K | $17M |
| Cash End of Period | $32M | $13M | $6M | $6M | $23M |
| Free Cash Flow | -$23M | -$26M | -$18M | -$13M | -$7M |